rs7482144

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The ENST00000380259.7(ENSG00000239920):​n.*1093C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 560,744 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.21 ( 15 hom., cov: 29)
Exomes 𝑓: 0.22 ( 1 hom. )

Consequence

ENSG00000239920
ENST00000380259.7 non_coding_transcript_exon

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.541
Variant links:
Genes affected
HBG2 (HGNC:4832): (hemoglobin subunit gamma 2) The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'- epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-5254939-G-A is Benign according to our data. Variant chr11-5254939-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 14984.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=1}.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.26 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBG2NM_000184.3 linkc.-211C>T upstream_gene_variant ENST00000336906.6 NP_000175.1 P69892D9YZU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000239920ENST00000380259.7 linkn.*1093C>T non_coding_transcript_exon_variant Exon 7 of 8 5 ENSP00000369609.3 A0A2U3TZJ3
ENSG00000239920ENST00000380259.7 linkn.*1093C>T 3_prime_UTR_variant Exon 7 of 8 5 ENSP00000369609.3 A0A2U3TZJ3
HBG2ENST00000336906.6 linkc.-211C>T upstream_gene_variant 1 NM_000184.3 ENSP00000338082.4 P69892
ENSG00000284931ENST00000642908.1 linkc.-211C>T upstream_gene_variant ENSP00000495346.1

Frequencies

GnomAD3 genomes
AF:
0.207
AC:
31089
AN:
150068
Hom.:
15
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.202
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.174
Gnomad EAS
AF:
0.110
Gnomad SAS
AF:
0.229
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.263
Gnomad OTH
AF:
0.210
GnomAD4 exome
AF:
0.218
AC:
89641
AN:
410562
Hom.:
1
Cov.:
0
AF XY:
0.219
AC XY:
47503
AN XY:
216468
show subpopulations
Gnomad4 AFR exome
AF:
0.124
Gnomad4 AMR exome
AF:
0.161
Gnomad4 ASJ exome
AF:
0.157
Gnomad4 EAS exome
AF:
0.117
Gnomad4 SAS exome
AF:
0.214
Gnomad4 FIN exome
AF:
0.191
Gnomad4 NFE exome
AF:
0.248
Gnomad4 OTH exome
AF:
0.207
GnomAD4 genome
AF:
0.207
AC:
31096
AN:
150182
Hom.:
15
Cov.:
29
AF XY:
0.203
AC XY:
14930
AN XY:
73372
show subpopulations
Gnomad4 AFR
AF:
0.143
Gnomad4 AMR
AF:
0.181
Gnomad4 ASJ
AF:
0.174
Gnomad4 EAS
AF:
0.110
Gnomad4 SAS
AF:
0.229
Gnomad4 FIN
AF:
0.188
Gnomad4 NFE
AF:
0.263
Gnomad4 OTH
AF:
0.211
Alfa
AF:
0.260
Hom.:
813

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 13, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The HBG2 c.-211C>T variant (rs7482144, rs1060499525, HbVar ID: 3260), also known as -158C>T and XmnI, is a common variant in the 5' untranslated region. While not associated with hereditary persistence of fetal hemoglobin (HPFH) in healthy adults, this variant has been described as a modifier of beta-thalassemia (Ma 2007, Nguyen 2010) and beta-globin variants such as Hb S (Akinbami 2016) due to its association with increased levels of HbF. This variant is also reported in ClinVar (Variation ID: 14984) and is found in the general population with an overall allele frequency of 20.7% (at least 6412/30916 alleles) in the Genome Aggregation Database. Based on available information, this variant is considered to be benign. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Akinbami AO et al. Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease. Hemoglobin. 2016;40(1):64-5. PMID: 26372199. Ma Q et al. Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia. Clin Genet. 2007 Dec;72(6):497-505. PMID: 17894837. Nguyen TK et al. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients. Blood Cells Mol Dis. 2010 Aug 15;45(2):124-7. PMID: 20472475. -

not specified Uncertain:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary persistence of fetal hemoglobin Uncertain:1
Dec 01, 2010
OMIM
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.3
DANN
Benign
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7482144; hg19: chr11-5276169; API